Postmenopausal: Clinical Trials

2 trials for Postmenopausal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2

Follow Postmenopausal: new trials by email Literature Review of Postmenopausal trials Research Report on Postmenopausal

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer
Biopsy of Breast, Copanlisib, Laboratory Biomarker Analysis - Estrogen Receptor Positive, HER2/Neu Negative
Phase 1TerminatedJonsson Comprehensive Cancer Center102017-08-022022-09-26
Effects of Denosumab on the Pharmacokinetics of Etanercept
Etanercept, Denosumab - Postmenopausal, Osteopenia
Phase 1TerminatedAmgen192011-03-012017-06-20

Narrower conditions

Arthritis (1)  ·  Arthritis, Rheumatoid (1)  ·  Bone Diseases, Metabolic (1)  ·  Breast Neoplasms (1)  ·  Osteoporosis (1)

Broader conditions

Skin and Connective Tissue Diseases (2)  ·  Autoimmune Diseases (1)  ·  Bone Diseases (1)  ·  Breast Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Rheumatic Diseases (1)  ·  Skin Diseases (1)

Interventions

Denosumab (1)  ·  Etanercept (1)  ·  Letrozole (1)  ·  copanlisib (1)  ·  palbociclib (1)

Sponsors

Amgen (1)  ·  Jonsson Comprehensive Cancer Center (1)

Countries

United States (2)

Top investigators

Sara Hurvitz (1)